CLINICAL TRIALS PROFILE FOR BUPIVACAINE LIPOSOME
✉ Email this page to a colleague
All Clinical Trials for BUPIVACAINE LIPOSOME
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT01507220 ↗ | A Health Economic Trial in Adult Patients Undergoing Open Colectomy MA402S23B301 | Terminated | Registrat-Mapi | Phase 4 | 2012-03-01 | This study is designed to compare the standard of care against EXPAREL (bupivacaine liposome extended-release injectable suspension) to determine if total opioid consumption is reduced when using EXPAREL therefore possibly reducing total hospitalization costs. |
| NCT01507220 ↗ | A Health Economic Trial in Adult Patients Undergoing Open Colectomy MA402S23B301 | Terminated | Pacira Pharmaceuticals, Inc | Phase 4 | 2012-03-01 | This study is designed to compare the standard of care against EXPAREL (bupivacaine liposome extended-release injectable suspension) to determine if total opioid consumption is reduced when using EXPAREL therefore possibly reducing total hospitalization costs. |
| NCT01507233 ↗ | A Health Economic Trial in Adult Patients Undergoing Open Colectomy MA402S23B302 | Terminated | Registrat-Mapi | Phase 4 | 2012-05-01 | This study is designed to compare the standard of care against EXPAREL (bupivacaine liposome extended-release injectable suspension) to determine if total opioid consumption is reduced when using EXPAREL, therefore possibly reducing total hospitalization costs. |
| NCT01507233 ↗ | A Health Economic Trial in Adult Patients Undergoing Open Colectomy MA402S23B302 | Terminated | Pacira Pharmaceuticals, Inc | Phase 4 | 2012-05-01 | This study is designed to compare the standard of care against EXPAREL (bupivacaine liposome extended-release injectable suspension) to determine if total opioid consumption is reduced when using EXPAREL, therefore possibly reducing total hospitalization costs. |
| NCT01507246 ↗ | Adult Patients Undergoing Open Colectomy MA402S23B303 | Completed | Registrat-Mapi | Phase 4 | 2011-12-01 | This study is designed to compare the standard of care against EXPAREL(R) to determine if total opioid consumption is reduced when using EXPAREL, therefore possibly reducing total hospitalization costs. |
| NCT01507246 ↗ | Adult Patients Undergoing Open Colectomy MA402S23B303 | Completed | Pacira Pharmaceuticals, Inc | Phase 4 | 2011-12-01 | This study is designed to compare the standard of care against EXPAREL(R) to determine if total opioid consumption is reduced when using EXPAREL, therefore possibly reducing total hospitalization costs. |
| NCT01509638 ↗ | A Health Economic Trial in Adult Patients Undergoing Ileostomy Reversal MA402S23B501 | Completed | Registrat-Mapi | Phase 4 | 2012-03-01 | This study is designed to compare the standard of care against EXPAREL (bupivacaine liposome injectable suspension) to determine if total opioid consumption is reduced when using EXPAREL, therefore possibly reducing total hospitalization costs. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for BUPIVACAINE LIPOSOME
Condition Name
Clinical Trial Locations for BUPIVACAINE LIPOSOME
Trials by Country
Clinical Trial Progress for BUPIVACAINE LIPOSOME
Clinical Trial Phase
Clinical Trial Sponsors for BUPIVACAINE LIPOSOME
Sponsor Name
